Two Sigma Investments
CAMP icon

Two Sigma Investments’s CAMP4 Therapeutics CAMP Stock Holding History

Two Sigma Investments’s Portfolio CAMP Stock Details CAMP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$480K Buy
108,875
+14,344
+15% +$68.1K ﹤0.01% 3767
2025
Q4 		$579K Sell
94,531
-2,840
-3% -$12.1K ﹤0.01% 3227
2025
Q3 		$292K Buy
+97,371
New +$180K ﹤0.01% 3221

Other funds holding CAMP

Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
5VM
5AM Venture Management San Francisco, California $360M AUM 345.76% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
VC
Vivo Capital Palo Alto, California $1.2B AUM 911.44% 1-Year Est. Return
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $77.1B AUM 42.89% 1-Year Est. Return
ES
Enavate Sciences Menlo Park, California $352M AUM 220.14% 1-Year Est. Return
ACM
AH Capital Management Menlo Park, California $1.29B AUM 26.81% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
TECP
Trails Edge Capital Partners Atlanta, Georgia $437M AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Two Sigma Investments's CAMP Position: Q1 2026 in Review

Two Sigma Investments increased its CAMP4 Therapeutics (CAMP) stake by 15% in Q1 2026, buying an estimated $68.1K and bringing the position to 108,875 shares worth $480K. The position accounts for ﹤0.01% of the portfolio, ranked #3767.

Two Sigma Investments first reported a position in CAMP in Q3 2025 and has held it in 3 quarters since. The position peaked at $579K in Q4 2025. 46 funds tracked by Wall St. Rank hold CAMP as of Q1 2026.

  • Two Sigma Investments held 108,875 shares of CAMP4 Therapeutics worth $480K as of Q1 2026.
  • Two Sigma Investments bought 14,344 CAMP4 Therapeutics shares in Q1 2026, an estimated $68.1K.
  • CAMP4 Therapeutics made up ﹤0.01% of Two Sigma Investments's portfolio in Q1 2026, its #3767 holding.
  • Two Sigma Investments first reported a position in CAMP4 Therapeutics in Q3 2025 and has held it in 3 quarters since.
  • Two Sigma Investments's CAMP4 Therapeutics position peaked at $579K in Q4 2025.
  • 46 funds tracked by Wall St. Rank held CAMP4 Therapeutics as of Q1 2026.

Based on Two Sigma Investments's 13F filing for Q1 2026, filed 15 May 2026.